Cancer treatment is one of the fastest-changing areas of drug development, as doctors now have access to immunotherapies, cell therapies, targeted biologics and tailored chemotherapeutic combinations.

Family input was solicited since the inception of the CPCCRN; however, it was conducted in a non-structured manner over the first two cycles (10 years) of the Network. This manuscript focuses on its ...

The Action Collaborative brings together leaders from academic and research institutions and key stakeholders to collaboratively work toward and share targeted actions on addressing and preventing ...